Health IT Workgroup’s Final Regulatory Recommendations Approved
This article was originally published in The Gray Sheet
Executive Summary
The final recommendations from the FDASIA workgroup urge the government to focus regulatory attention on the highest risk products, while minimizing requirements for the large swath of health IT offerings that are lower risk. The recommendations, which largely align with a prior draft version, will inform a health IT regulatory framework proposal due to Congress in January.
You may also be interested in...
mHealth Experts Call For App Review Organizations To Ensure Quality
In a Journal of the American Medical Association article, three mobile Health experts call for private, unaffiliated organizations in the mold of Underwriters Laboratory to review health apps for quality.
McKesson Recall Dovetails With Broader Health IT Reg Debate
One of McKesson Corp.’s clinical decision support software products underwent a class I recall, but it may not have been subject to this type of FDA enforcement if legislation currently under consideration in Congress was law.
Health IT Reg Bill Sparks Debate; AdvaMed Tries To Address “Technical Concerns”
The PROTECT Act, introduced by Sens. Fischer, R-Neb., and King, I-Maine, earlier this month to restrict FDA oversight of software tools has already triggered some high-profile discussion, with a USA Today op-ed from sponsors and an opposition letter from consumer groups. AdvaMed, meanwhile, is playing more of a behind-the-scene role.